Evaluation of hirsutism

Last reviewed: 17 Aug 2025
Last updated: 24 Jul 2025

Summary

Diagnósticos diferenciais

comuns

  • Polycystic ovary syndrome
  • Idiopathic hirsutism
Detalhes completos

Incomuns

  • Hyperprolactinemia
  • Nonclassic congenital adrenal hyperplasia
  • Cushing syndrome
  • Androgenic drugs
  • Androgen-secreting ovarian tumor
  • Ovarian hyperthecosis
  • Adrenocortical carcinoma
Detalhes completos

Colaboradores

Autores

Stephen L. Atkin, PhD, FRCP

Professor of Medicine

Head of School of Postgraduate Studies & Research

The Royal College of Surgeons in Ireland - Bahrain

Busaiteen

Bahrain

Declarações

SLA has no competing interests.

Thozhukat Sathyapalan, MD, MRCP FRCPE

Professor of Endocrinology/Honorary Consultant Endocrinologist

Academic Endocrinology, Diabetes and Metabolism

Hull York Medical School

Michael White Diabetes Centre

Hull Royal Infirmary

Hull

UK

Declarações

TS declares that he has received educational grants and clinical trials funding from Novo Nordisk, Eli Lillly, and Novartis.

Agradecimentos

Dr Stephen L. Atkin and Dr Thozhukat Sathyapalan would like to gratefully acknowledge Dr Shehzad Basaria and Dr Milena Braga-Basaria, the previous contributors to this topic.

Declarações

SB and MBB declared that they had no competing interests.

Revisores

Joe McKenna, MD

Professor of Investigative Endocrinology

University College

Dublin

Ireland

Declarações

JM declares that he has no competing interests.

Udaya Kabadi, MD, FRCP(C), FACP, FACE

Director

Endocrinology

Department of Internal Medicine

VA Medical Center

University of Iowa

Iowa City

IA

Disclosures

UK declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1233-57.Full text  Abstract

Elliott J, Liu K, Motan T. Guideline no. 444: hirsutism: evaluation and treatment. J Obstet Gynaecol Can. 2023 Dec;45(12):102272. Abstract

Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023 Oct;120(4):767-93.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer